nach oben

Rheumatology International

Erschienen in:

19.05.2017 | Genes and Disease

Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis

verfasst von: Hai Lin, Yi-Zhen Gong

Erschienen in: Rheumatology International | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Many studies have estimated the correlation between HLA-B27 polymorphisms and ankylosing spondylitis (AS). However, the results were controversial. Therefore, we performed this meta-analysis to determine the association of HLA-B*27 polymorphisms with AS and investigate the impacts of HLA-B27 on the clinical symptoms of AS patients. A comprehensive search was performed in PubMed, Web of Science and Embase databases to retrieve the eligible studies, which addressed the association between HLA-B27 polymorphisms and AS susceptibility. The correlation in fixed-effect model was estimated using the relative risk (RR) and 95% confidence intervals (CI). Finally, 41 studies were included in this meta-analysis, among which 35 studies were used to analyze the correlation between HLA-B27 and AS. And 11 studies were applied to estimate the effects of HLA-B27 on the clinical characteristics of AS patients. Besides, our meta-analysis was composed of 8993 AS patients and 19,254 healthy controls. The results suggested that HLA-B27, HLA-B27*02 and HLA-B27*04 were positively in relation to AS (RR_HLA-B27 (95% CI) 16.02 (13.85, 18.54), P < 0.001; RR_HLA-B*2702 (95% CI) 1.28 (1.08, 1.53), P = 0.005; RR_HLA-B27*04 (95% CI) 1.14 (1.01, 1.29), P = 0.041). Moreover, positive association was observed between HLA-B27 and sex (male) [RR (95% CI) 1.10 (1.05, 1.15), P < 0.001], family history [RR (95% CI) 1.10 (1.06, 1.140), P < 0.001], uveitis [RR (95% CI) 1.07 (1.03, 1.11), P < 0001], peripheral joint involvement [RR (95% CI) 1.04 (1.01,1.07), P = 0.013] and hip joints involvement [RR (95% CI) 1.06 (1.02, 1.10), P = 0.003]. In addition, we also found that HLA-B27*04 showed association with peripheral joint involvement [RR (95% CI) 1.13 (1.05–1.23), P = 0.002]. In conclusion, the current meta-analysis indicates that HLA-B27, especially, its subtypes (HLA-B27*02 and HLA-B27*04) may be potential risk factors for AS.

Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390CrossRefPubMed

Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377:2127–2137CrossRefPubMed

Gao X, Wendling D, Botteman MF, Carter JA, Rao S et al (2012) Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents. J Med Econ 15:1054–1063CrossRefPubMed

Jang JH, Ward MM, Rucker AN, Reveille JD, Davis JC Jr et al (2011) Ankylosing spondylitis: patterns of radiographic involvement—a re-examination of accepted principles in a cohort of 769 patients. Radiology 258:192–198CrossRefPubMedPubMedCentral

Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904CrossRefPubMedPubMedCentral

Jeong H, Eun YH, Kim IY, Kim H, Ahn JK et al (2016) Drug survival of tumor necrosis factor alpha inhibitors in patients with ankylosing spondylitis in Korea. Korean J Intern Med. doi:10.3904/kjim.2016.042

Liu J, Dong Z, Zhu Q, He D, Ma Y et al (2016) TNF-alpha promoter polymorphisms predict the response to etanercept more powerfully than that to infliximab/adalimumab in spondyloarthritis. Sci Rep 6:32202CrossRefPubMedPubMedCentral

Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 32:732–734PubMed

Zavada J, Uher M, Sisol K, Forejtova S, Jarosova K et al (2016) A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study. Ann Rheum Dis 75:96–102CrossRefPubMed

10.

Nossent JC, Sagen-Johnsen S, Bakland G (2014) Tumor necrosis factor-alpha promoter-308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-alpha and does not predict TNF inhibitor response. J Rheumatol 41:1675–1682CrossRefPubMed

11.

Bowness P (2015) Hla-B27. Annu Rev Immunol 33:29–48CrossRefPubMed

12.

Kim K, Bang SY, Lee S, Lee HS, Shim SC et al (2015) An HLA-C amino acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population. Arthritis Res Ther 17:342CrossRefPubMedPubMedCentral

13.

Al-Qadi R, Salih SF, AlDoski HJ, Nabeel M, Ali JH et al (2015) Association of HLA-B*27 with ankylosing spondylitis in Kurdish patients. Int J Rheum Dis. doi:10.1111/1756-185X.12605 PubMed

14.

Akassou A, Yacoubi H, Jamil A, Dakka N, Amzazi S et al (2015) Prevalence of HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis. Rheumatol Int 35:1889–1894CrossRefPubMed

15.

Diyarbakir E, Eyerci N, Melikoglu M, Topcu A, Pirim I (2012) HLA B27 subtype distribution among patients with ankylosing spondylitis in eastern Turkey. Genet Test Mol Biomark 16:456–458CrossRef

16.

Qi J, Li Q, Lin Z, Liao Z, Wei Q et al (2013) Higher risk of uveitis and dactylitis and older age of onset among ankylosing spondylitis patients with HLA-B*2705 than patients with HLA-B*2704 in the Chinese population. Tissue Antigens 82:380–386CrossRefPubMed

17.

Yi L, Wang J, Guo X, Espitia MG, Chen E et al (2013) Profiling of hla-B alleles for association studies with ankylosing spondylitis in the chinese population. Open Rheumatol J 7:51–54CrossRefPubMedPubMedCentral

18.

Li H, Li Q, Ji C, Gu J (2016) Ankylosing spondylitis patients with HLA-B*2704 have More uveitis than patients with HLA-B*2705 in a North Chinese population. Ocul Immunol Inflamm 1–5: doi:10.1080/09273948.2016.1188967

19.

Diaz-Pena R, Vidal-Castineira JR, Lopez-Vazquez A, Lopez-Larrea C (2016) HLA-B*40:01 is associated with ankylosing spondylitis in HLA-B27-positive populations. J Rheumatol 43:1255–1256CrossRefPubMed

20.

Wei JC, Sung-Ching HW, Hsu YW, Wen YF, Wang WC et al (2015) Interaction between HLA-B60 and HLA-B27 as a better predictor of ankylosing spondylitis in a Taiwanese population. PLoS ONE 10:e0137189CrossRefPubMedPubMedCentral

21.

Videm V, Cortes A, Thomas R, Brown MA (2014) Current smoking is associated with incident ankylosing spondylitis—the HUNT population-based Norwegian health study. J Rheumatol 41:2041–2048CrossRefPubMed

22.

van Gaalen FA, Verduijn W, Roelen DL, Bohringer S, Huizinga TW et al (2013) Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis. Ann Rheum Dis 72:974–978CrossRefPubMed

23.

Acar M, Cora T, Tunc R, Acar H (2012) HLA-B27 subtypes in Turkish patients with ankylosing spondylitis and healthy controls. Rheumatol Int 32:3103–3105CrossRefPubMed

24.

al Attia HM, Sherif AM, Hossain MM, Ahmed YH (1998) The demographic and clinical spectrum of Arab versus Asian patients with ankylosing spondylitis in the UAE. Rheumatol Int 17:193–196CrossRefPubMed

25.

Liu Y, Jiang L, Cai Q, Danoy P, Barnardo MC et al (2010) Predominant association of HLA-B*2704 with ankylosing spondylitis in Chinese Han patients. Tissue Antigens 75:61–64CrossRefPubMed

26.

Mou Y, Wu Z, Gu J, Liao Z, Lin Z et al (2010) HLA-B27 polymorphism in patients with juvenile and adult-onset ankylosing spondylitis in Southern China. Tissue Antigens 75:56–60CrossRefPubMed

27.

Harfouch EI, Al-Cheikh SA (2011) HLA-B27 and its subtypes in Syrian patients with ankylosing spondylitis. Saudi Med J 32:364–368PubMed

28.

Cipriani A, Rivera S, Hassanhi M, Marquez G, Hernandez R et al (2003) HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. Hum Immunol 64:745–749CrossRefPubMed

29.

Kchir MM, Hamdi W, Laadhar L, Kochbati S, Kaffel D et al (2010) HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study). Rheumatol Int 30:933–939CrossRefPubMed

30.

Chavan H, Samant R, Deshpande A, Mankeshwar R (2011) Correlation of HLA B27 subtypes with clinical features of ankylosing spondylitis. Int J Rheum Dis 14:369–374CrossRefPubMed

31.

Pazar B, Safrany E, Gergely P, Szanto S, Szekanecz Z et al (2010) Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. J Rheumatol 37:379–384CrossRefPubMed

32.

Ben Radhia K, Ayed-Jendoubi S, Sfar I, Ben Romdhane T, Makhlouf M et al (2008) Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine 75:172–175CrossRefPubMed

33.

Liu X, Hu LH, Li YR, Chen FH, Ning Y et al (2010) The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China. Rheumatol Int 30:587–590CrossRefPubMed

34.

Alaez C, Gazit E, Ibarrola B, Yaron M, Livneh A et al (2007) Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch Med Res 38:452–455CrossRefPubMed

35.

Birinci A, Bilgici A, Kuru O, Durupinar B (2006) HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis. Rheumatol Int 26:285–287CrossRefPubMed

36.

Gonzalez S, Garcia-Fernandez S, Martinez-Borra J, Blanco-Gelaz MA, Rodrigo L et al (2002) High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain. Hum Immunol 63:673–676CrossRefPubMed

37.

Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez-Alvarez B et al (2006) Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 8:R101CrossRefPubMedPubMedCentral

38.

Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D, Stylianou G, Kokkofitou A et al (2004) HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707. Hum Immunol 65:1451–1454CrossRefPubMed

39.

Lopez-Larrea C, Gonzalez-Roces S, Pena M, Dominguez O, Coto E et al (1995) Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Hum Immunol 43:174–180CrossRefPubMed

40.

Gonzalez-Roces S, Alvarez MV, Gonzalez S, Dieye A, Makni H et al (1997) HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 49:116–123CrossRefPubMed

41.

Ren EC, Koh WH, Sim D, Boey ML, Wee GB et al (1997) Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens 49:67–69CrossRefPubMed

42.

Hou TY, Chen HC, Chen CH, Chang DM, Liu FC et al (2007) Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience. Intern Med J 37:749–752PubMed

43.

Ma HJ, Hu FP (2006) Diversity of human leukocyte antigen-B27 alleles in Han population of Hunan province, southern China. Tissue Antigens 68:163–166CrossRefPubMed

44.

Chou CT, Chen JM, Hsu CM, Chen SJ (2003) HLA-B27 and its subtypes in 4 Taiwanese aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol 30:321–325PubMed

45.

Park SH, Kim J, Kim SG, Kim SK, Chung WT et al (2009) Human leucocyte antigen-B27 subtypes in Korean patients with ankylosing spondylitis: higher B*2705 in the patient group. Int J Rheum Dis 12:34–38CrossRefPubMed

46.

Yang M, Xu M, Pan X, Hu Z, Li Q et al (2013) Epidemiological comparison of clinical manifestations according to HLA-B*27 carrier status of Chinese ankylosing spondylitis patients. Tissue Antigens 82:338–343CrossRefPubMed

47.

Wu Z, Lin Z, Wei Q, Gu J (2009) Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism. Rheumatol Int 29:389–392CrossRefPubMed

48.

Sun L, Wu R, Xue Q, Wang F, Lu P (2016) Risk factors of uveitis in ankylosing spondylitis: an observational study. Medicine (Baltimore) 95:e4233CrossRef

49.

Yang T, Duan Z, Wu S, Liu S, Zeng Z et al (2014) Association of HLA-B27 genetic polymorphisms with ankylosing spondylitis susceptibility worldwide: a meta-analysis. Modern Rheumatol 24:150–161CrossRef

50.

Zhang L, Liu JL, Zhang YJ, Wang H (2011) Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin Exp Rheumatol 29:285–292PubMed

51.

Kim TJ, Na KS, Lee HJ, Lee B, Kim TH (2009) HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol 27:574–579PubMed

Titel: Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis
verfasst von: Hai Lin
Yi-Zhen Gong
Publikationsdatum: 19.05.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 8/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-017-3741-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Periodontal disease in Chinese patients with systemic lupus erythematosus

A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity

Association study of estrogen receptor alpha gene polymorphisms with bone mass assessed by quantitative ultrasound in young adults

Women with silicone breast implants and autoimmune inflammatory syndrome induced by adjuvants: description of three patients and a critical review of the literature

A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis